Advertisement
Shengda is a leading manufacturer of pediatric pharmaceuticals,specializing in antibiotic research and development and has approximately 75product licenses approved by the SFDA in China.
Advertisement
Mr. Zhiqiang Han, President and Chief Operating Officer of BMP Sunstone,stated, "We look forward to the partnership with Shengda. While we are notinterested in entering the low-end generic antibiotics market, the Shengdaproducts we intend to acquire specifically target the oral pediatrics market.They fit nicely under our GoodBaby brand and also complement our pediatricsfranchise in both the OTC and Rx markets. Utilizing our existing salescoverage and nationally-recognized brand, we intend to realize synergiesimmediately by increasing sales volume and improving sales margins."
Han continued, "Shengda's main products are amoxicillin tablets, capsulesand clavulanate potassium compound preparation. These products include someof the most widely prescribed and effective pediatric medicines with dosagesand flavors specifically formulated for children's use. We look forward tocombining Sunstone's platform in pediatric pharmaceuticals, Shengda's productportfolio and R&D expertise with BMP Sunstone's distribution network into anational-leading platform in pediatrics."
About BMP Sunstone Corporation
BMP Sunstone Corporation is a specialty pharmaceutical company that isbuilding a proprietary portfolio of branded pharmaceutical and healthcareproducts in China and is pursuing partnerships with other companies seeking toenter the Chinese pharmaceutical market. It is the only U.S. public companyto offer industry partners a comprehensive suite of market-entry services inChina that includes pre-market entry analysis, clinical trial management,product registration, market research, as well as pharmaceutical marketing anddistribution. The Company provides distribution services for a wide range ofproducts, including Western medicines, traditional Chinese medicines,bio-chemical medicines, medical applications, branded generic pharmaceuticals,over-the-counter healthcare products, and home healthcare supplies andequipments. BMP Sunstone's proprietary portfolio primarily focuses on women'shealth and pediatrics. The Company is headquartered in Plymouth Meeting,Pennsylvania.
Safe Harbor Statement
This news release contains forward-looking statements as defined by thePrivate Securities Litigation Reform Act of 1995. Forward-looking statementsinclude statements concerning plans, objectives, goals, strategies, futureevents or performance, and underlying assumptions and other statements thatare other than statements of historical facts, including but not limited tostatements about the completion, terms, benefits and synergies of the proposedacquisition of 75% of Shengda. These statements are subject to uncertaintiesand risks including, but not limited to, negotiating definitive terms anddefinitive agreements regarding the proposed acquisition, satisfying theconditions in such definitive agreements, regulatory review, general financial,economic, a
